6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol
-
6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol
structure -
-
CAS No:
116409-29-1
-
Formula:
C21H25NO6
-
Chemical Name:
6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol
-
Synonyms:
116409-29-1;NSC370284;NSC 370284;6-(1-Pyrrolidinyl(3,4,5-trimethoxyphenyl)methyl)-1,3-benzodioxol-5-ol;6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol;cid_340208;CHEMBL1557864;SCHEMBL21808862;BDBM41970;DTXSID70922063;AKOS024282084;MCULE-7381068085;NSC-370284;NCI60_003410;ST051981;6-[pyrrolidino-(3,4,5-trimethoxyphenyl)methyl]sesamol;6-[(1-Pyrrolidinyl)(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol;6-[(3,5-Trimethoxyphenyl)-1-pyrrolidinylmethyl]-1,3-benzodioxol-5-ol;6-[1-pyrrolidinyl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol;{6-[(3,4,5-Trimethoxyphenyl)-1-pyrrolidinylmethyl]-1,} 3-benzodioxol-5-ol;6-(Pyrrolidin-1-yl(3,4,5-trimethoxyphenyl)methyl)benzo[d][1,3]dioxol-5-ol;6-[(Pyrrolidin-1-yl)(3,4,5-trimethoxyphenyl)methyl]-2H-1,3-benzodioxol-5-ol;6-[pyrrolidinyl(3,4,5-trimethoxyphenyl)methyl]-2H-benzo[d]1,3-dioxolen-5-ol
- Categories:
-
CAS No:
6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol Basic Attributes
387.4 g/mol
387.16818752 g/mol
370284
Computed Properties
Molecular Weight:387.4
XLogP3:3.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:6
Exact Mass:387.16818752
Monoisotopic Mass:387.16818752
Topological Polar Surface Area:69.6
Heavy Atom Count:28
Complexity:487
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol
-
CN
2 YRS
Business licensedTrader Supplier of Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524,Milbemycin oxime,MeloxicamInquiryUnit Price: $1 /G FOBCAS No.: 116409-29-1Grade: Reagent GradeContent: 99%
Latest News on 6-[pyrrolidin-1-yl-(3,4,5-trimethoxyphenyl)methyl]-1,3-benzodioxol-5-ol
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4
Request for Quotation